RxDoctor Payments Data
★ My doctorsLook up a doctor →

Gordon Auyeung

Family Medicine · New York, NYNPI 1043741291

Payments from drug & device makers

$2,098in general payments, 2019–2025

Across 103 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$337
  • Novo Nordisk$245
  • Amarin Pharma, Inc.$198
  • Pfizer$167
  • Boehringer Ingelheim$163
  • GSK$114
  • plus $874 from 15 others

What the payments were for

  • Food & beverage$2,07899%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca19$337
Novo Nordisk11$245
Amarin Pharma, Inc.9$198
Pfizer6$167
Boehringer Ingelheim7$163
GSK6$114
Biogen6$114
Merck5$111
Amgen6$108
AbbVie4$82
Esperion Therapeutics, Inc.4$77
Lilly USA, LLC3$71
Bayer3$60
Seqirus USA Inc3$54
IBSA Pharma Inc.2$46
Kowa Pharmaceuticals America, Inc.2$37
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$29
Intra-sana Laboratories1$28
Genentech USA, Inc.2$27
Axsome Therapeutics, Inc.1$16
Idorsia Pharmaceuticals US Inc1$14

How this compares

$2,098 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Other family medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →